This may reflect the existence of an alternative ILC- and mast cell-independent axis of IL-33-mediated immunity that compensates for the absent ILC and is visualised in these extreme models of effector cell deficiency. Here, CCL27 is linked to hyperinsulinemic hypoglycemia, familial, 4.